These results indicated that ESRP1 could bind to exon 5 of CLSTN1 and induce skip splicing of exon 11, which was correlated with a low risk of lymph node metastasis and superior survival. This evidence concerns the gene ESRP1 and metastatic malignant neoplasm in the lymph nodes.